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Survival of dental implants placed in
autogenous bone grafts and bone flaps in
head and neck oncology patients: a
systematic review
Dominic P. Laverty1*, Robert Kelly2 and Owen Addison2,3
Abstract
Using implants to retain prostheses as part of the oral rehabilitation of head and neck cancer patients is an
increasingly common treatment modality, particularly in transported bone which is used to reconstruct defects
following oncological surgical resection. The aim of this systematic review is to evaluate the survival of dental
implants placed into autogenous bone grafts and flaps, in head and neck cancer patients. MEDLINE, EMBASE,
CENTRAL and Science Direct databases were searched (1980-August 2017) for studies evaluating intra-oral implant
placement into autogenous bone grafts and flaps in H&N cancer patients. Twenty articles were included reporting
on 1905 implants placed into autogenous bone in head and neck cancer patients. Implant survival varied from 54
to 100% within the studies with 11 studies reporting implant survival of over 90%. In conclusion, intra-oral implant
survival in autogenous bone grafts in head and neck oncology patients is promising, however inconsistencies in
data reporting and in outcome definitions precludes formal meta-analysis.
Keywords: Dental implants, Autogenous bone graft, Head and neck oncology, Implant survival
Review
Introduction
Rationale
The use of implants to retain prostheses as part of oral
and dental rehabilitation of head and neck (H&N) cancer
patients is becoming an increasingly common treatment
approach [1–3]. A number of benefits advocating implant
anchorage over conventionally secured prostheses have
been proposed [4] but importantly include a significant
improvement in the reported quality of life (QoL) of
patients [5].
Patients with H&N cancer often undergo ablative sur-
gery with or without surgical reconstruction, radiotherapy
and chemotherapy [4, 6]. Both surgical and non-surgical
interventions can lead to significant disability, including
facial deformity, loss of hard and soft tissue, impaired
speech, swallowing and mastication [7]. Oral and dental
rehabilitation has conventionally required the use of re-
movable prostheses to obturate defects, to replace missing
tissue structures and to restore function and aesthetics. In
this patient group, removable prostheses are often poorly
tolerated, are difficult for the patient to maintain and
frequently fail to fully achieve the intended functional
improvement. The use of dental implants has been pro-
posed to enable secure anchorage for prostheses, reduced
loading on vulnerable tissues and provide a better func-
tional and cosmetic solution [8].
However, dental implants can only be placed if there is
sufficient bone to encase the implant so that a direct inter-
face between the implant surface and bone can be
achieved. Frequently following resective surgery, insuffi-
cient bone volume remains and bony reconstruction of
the surgical defect is required to enable successful dental
implant placement [9]. Patients are commonly recon-
structed with either a non-vascularised bone graft or a
composite free flap. A non-vascularised bone graft is a free
piece of non-vascularised bone (or bone substitute) that is
placed in the tissues. A free flap is a vascularised piece of
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bone (pedicled), which is being increasingly used to recon-
struct tumour patients.
High ‘survival’ and ‘success’ rates have been reported in
the literature for dental implants placed into autogenous
bone grafts in healthy patients but notably the success
rates remain lower for implants placed into healthy native
bone [10, 11]. With the increasing use of complex recon-
structive techniques in rehabilitation following H&N
cancer and the placement of dental implants into trans-
ported bone, there is a need to appraise the highly varied
evidence that is currently available in order to help inform
clinical decision making.
Objectives
It is the aim of this systematic review to evaluate the
survival of dental implants placed into autogenous bone
grafts, in H&N oncology patients.
Methods
Protocol
The Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) [12, 13] for describing and
summarising the results of our review was used [12, 13].
A quality assessment of all selected full-text articles
was performed using the Methodological Index for Non-
Randomized Studies (MINORS) [14] assessment tool to
assess the risk of bias of the included studies. The
MINORS scoring list consists of 12 items, eight apply to
non-comparative studies, and a further four apply to
comparative studies. Items are scored as 0 (not
reported), 1 (reported but inadequate), and 2 (reported
and adequate) with this then totalled up to give a score
with the higher scores representing a reduced risk of
bias [14]. This was chosen over the Cochrane collabora-
tions’ tool for assessing risk of bias for randomised
controlled studies since none of the studies included
were randomised control trials.
Eligibility criteria
Inclusion criteria
Studies that met the following criteria where included:
1. Dental implant placement into patients with cancer
of the H&N.
2. Dental implants placed into autogenous bone grafts.
3. Studies performed on humans.
4. Patients over 18 years old, or if there are patients
under 18 years old within the study that these
patients and their data can be removed from the
analysis.
5. English language articles.
6. Any study design reporting on at least 35 dental
implants or 20 patients who have had implants
placed into autogenous bone.
7. Data related to implant number and implant
survival in autogenous bone grafts that was either
directly reported or can be calculated from data
within the study.
Exclusion criteria
Studies were excluded if they met the following criteria:
1. Studies that reported on craniofacial or extra-oral
implants only.
2. No reported implant survival or an inability to
calculate implant number or survival from reported
data.
3. Studies reporting on patients under 18 years old
where there no ability to remove these patients and
their data from the analysis.
4. Laboratory or animal-based studies.
5. Studies with less than 20 patients or 35 dental
implants placed into autogenous bone grafts.
6. Review articles.
Information sources
Four electronic databases were used to systematically
search the available literature: (1) The National Library of
Medicine (MEDLINE via PubMed), (2) EMBASE, (3)
Cochrane Central Register of Controlled Trials and (4) Sci-
ence Direct. The searches were limited to studies involving
human subjects and publication dates from January 1980 to
August 2017 that satisfied the inclusion criteria.
Search
The following search terms were used: Population: (<[text
words] dental implant OR dental implant* OR oral
implant OR oral implants OR osseointegrated implants
OR endosseous implant OR dental implantation <[MeSH
terms/all subheadings] AND (<[text words] head neck OR
squamous cell carcinoma OR oncology OR tumour OR
cancer OR malignant OR neoplasm <[MeSH terms/all
subheadings] AND Intervention: free flap OR vascularized
flap OR hard tissue graft OR micro vascularized flap OR
micro anastomosed flap OR anastomosed flap OR native
bone OR DCIA OR deep circumflex iliac artery OR radial
OR scapula OR fibula OR iliac OR rib OR costochondral
<[MeSH terms/all subheadings].
Study selection
Two reviewers (DL and RK) carried out the primary
search by screening independently the titles and abstracts
and identifying the studies appearing to meet the inclusion
criteria. Studies with insufficient information in the title
and abstract to make a clear decision were identified and
the full paper was reviewed. Those studies selected for
evaluation of the full manuscript were carried out inde-
pendently by the same reviewers who determined the final
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inclusion. Any disagreement was resolved by discussion
with a third independent reviewer (OA). The reasons for
rejecting studies at this or subsequent stages were recorded.
Data collection process
Two reviewers (DL and RK) then independently extracted
the data using a bespoke data extraction form. Any
disagreement was resolved by discussion with a third
reviewer (OA). Studies with missing or incomplete data
were excluded and reference lists of the selected studies
were checked for cross-references to search for papers
that might meet the eligibility criteria for inclusion.
Data items
Data was collected for implant survival, implant success,
implant failure, implant complications, surgical implant
placement protocol, implant system used, clinical follow-
up, how the author defined success/survival, the type of
autogenous bone graft, implant site, the prosthodontic re-
habilitation and type of cancer, and the use of radiotherapy
were documented where possible.
Risk of bias in individual studies
A quality assessment of all selected full-text articles was
performed using the Methodological Index for Non-
Randomised Studies (MINORS) [14] assessment tool.
Summary measures
The main outcome measure was implant survival. This
review will define implant survival as an implant still in
situ that has not been removed or lost at the census date
and thus implant failure defined as an implant that has
been removed or lost and is no longer in situ.
Synthesis of results
The survival and success figures documented where pos-
sible are taken directly from the study; however, where the
study did not specifically document the survival or success
of implants placed into autogenous bone as a percentage,
this was calculated from the data provided (as a function
of surviving or successful implants from total reported as
placed), and studies that lacked data to calculate this were
rejected as part of the secondary screening process.
Additional analyses
No further analyse was carried out.
Results
Study selection
Searches of EMBASE, the Cochrane Central Register of
Controlled Trials, Science Direct and MEDLINE generated
619 articles. After duplicate articles were removed, 566
unique articles were remaining. After the review of the titles
and abstracts, 151 articles were accepted for further consid-
eration, and 415 were rejected. After the full text was
attained and reviewed for the 151 articles, 131 articles were
rejected leaving 20 articles to be included in the systematic
review (Fig. 1).
Study characteristics
The following data was extracted from the studies; study
design, centres (single vs multiple centres), patient demo-
graphics (patient age, H&N cancer diagnosis), treatment
Fig. 1 Flow chart of study selection procedure
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modalities (surgery, radiotherapy, chemotherapy), donor site
of autogenous bone graft, outcome measures, implant de-
tails (implant system, implant number, implant site, type of
bone implant placed into (non-vascularised vs vascularised/
free flap), implant placement surgical protocol implant
survival/success/failure figures), implant definitions (implant
survival/success/failure), type of prosthetic rehabilitation
(fixed vs removable), and any reported complications.
Risk of bias within studies
There were varying scores attained by the studies using
the MINORS assessment tool, ranging from 7/16 to 13/16
representing varying degrees of bias within the studies
(Table 1).
Statistical analysis
Due to the lack of controlled studies and the heterogeneity
of the studies concerning patient selection, surgical proto-
cols, implant loading, follow-up and prosthetic rehabilita-
tion, implant survival definitions and figures, measurement
protocols, and inconsistency in data reporting a formal
meta-analysis would be statistically inappropriate and was
not conducted. Descriptive statistics where used to inter-
pret and present the data from these studies.
Results of the studies
Descriptive data extraction was carried out for the 20
studies and is summarised in Tables 1 and 2. All studies
were retrospective observational studies in design with the
majority undertaken at single centres; however, for 3 stud-
ies, this was unclear (Schultes et al. [15], Yerit et al. [16],
Linsen et al. [17]). These 20 studies were published over a
range of 21 years (1996 to 2017) and provide cumulative
data on 1905 implants placed into autogenous bone grafts
in H&N cancer patients with both benign and malignant
tumours being reported. The exact patient number for
this intervention within some of the studies was unclear
as a result of the studies reporting on implant rather than
patient number or there was an inability to identify which
population received dental implants to identify patient
numbers. One study (Chiapasco et al. [18]) included
reported on patients under 18 years old (two patients in
total); however, these patients and their data could be
removed from the analysis.
Implants were placed into both vascularised and non-
vascularised autogenous bone grafts, with a number of
donor sites being reported. (Tables 2 and 3) These implants
were placed in a variety of intra-oral sites with implants
placed into autogenous bone grafts within the mandible
reported in eight studies and bi-maxillary placement in nine
studies, and in three studies, it was unknown where the im-
plant fixtures were placed other than that they were placed
into autogenous bone grafts (Linsen et al. [17], Fenlon et al.
[19], Ch’ng et al. [20]). There were no studies where im-
plants were placed solely in the reconstructed maxilla.
Radiotherapy to the autogenous bone graft/implant
site was reported in 16 studies. Two studies (Wang et al.
[21], Zou et al. [22]) reported that radiotherapy was not
carried out on the study population and in 1 study (Yerit
et al. [16]) bone graft sites were not irradiated. One
study (Chiapasco et al. 2008 [23]) failed to report
whether radiotherapy was carried out or not on the
study population. Of 20 studies included in the system-
atic review, only 7 studies reported on outcomes related
to implant survival in irradiated autogenous bone grafts
(Barrowman et al. [7], Fenlon et al. [19], Ch’ng et al.
[20], Buddula et al. [24], Fierz et al. [25], Teoh et al. [26],
Burgess et al. [27]).
The surgical and loading implant protocols were re-
ported in 17 studies with no description given in 3 studies
(Barrowman et al. [7], Fierz et al. [25], Hessling et al. [28]).
The implant placement protocols were diverse with
variables including the use of surgical templates/guides,
primary and/or secondary implant placement following
autogenous bone grafting, and immediate and/or delayed
implant loading; however, the majority of the studies
reported on delayed implant placement following initial
healing of the transported bone graft and delayed loading
of the implant fixtures. Six studies reported primary im-
plant placement (Fenlon et al. [19], Ch’ng et al. [20], Zou
et al. [22], Burgess et al. [27], Wu et al. [30], Watzinger et
al. [29],) and one study reported immediate implant load-
ing (Chiapasco et al. [18]). Additional procedures were
also reported which include removal of reconstruction
plates and screws at the time of implant placement, bone
condensing to enhance the bone density, and further peri-
implant surgery in the form of debulking of soft tissues,
gingivoplasty/vestibuloplasty and free mucosal grafts to
optimise the soft tissue conditions (Table 1). Prosthodon-
tic reconstruction of the implant fixture was reported in
15 of the studies which included fixed and removable
prosthesis and is summarised in Table 1.
Overall implant survival
The overall implant survival of implants placed into
autogenous bone grafts varied highly (both at implant and
patient levels) between the included studies ranging from
100% with a mean follow-up of 3.5 years ± 0.3 years in a
study by Wang et al. [30] to 54% with a mean follow-up 5.
4 years ± 3.2 years by Yerit et al. [16].,(at an implant level)
(Table 2).
Eleven studies compared implant survival in autogenous
bone grafts to that in native bone within their studies.
Nine of these studies (Barrowman et al. [7], Yerit et al.
[16], Linsen et al. [17], Fenlon et al. [19], Ch’ng et al. [20],
Hessling et al. [28], Watzinger et al. [29], Shaw et al. [31],
Klein et al. [32]) reported higher implant failure rates
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within autogenous bone grafts than those within implants
placed into the native bone; however, two studies
(Buddula et al. [24], Teoh et al. [26]) reported no signifi-
cant difference.
Autogenous bone graft type and implant survival
Seventeen studies reported on the specific bone graft
type (non-vascularised or vascularised) into which the
implants were placed. In the remaining three studies
(Buddula et al. [24], Fierz et al. [25], Yerit et al. [16]), this
distinction was not possible.
Of these 17 studies, 8 studies reported on implant
survival in non-vascularised bone grafts and 14 studies
reported on implant survival in vascularised bone grafts
with 5 studies (Barrowman et al. [7], Hessling et al. [28],
Watzinger et al. [29], Shaw et al. [31], Chiapasco et al.
[33]), therefore reporting on implant survival in both
non-vascularised and vascularised bone grafts within
their study (Table 3). Implant survival appears to be
higher for those implants placed into vascularised bone
grafts in comparison to non-vascularised bone grafts. Of
the five studies reporting on both vascularised and non-
vascularised bone grafts, three of these studies (Barrowman
et al. [7], Watzinger et al. [29], Chiapasco et al. [33])
reported higher implant survival in vascularised bone grafts
whereas the other two studies (Hessling et al. [28], Shaw et
al. [31]) reported higher implant survival in non-
vascularised bone grafts. Shaw et al. [31] reported that im-
plants placed into ‘vascularized bone graft were superior to
non-vascularized bone. In particular, those implants in
composite radial forearm flaps performed badly. With the
proportion of patients with implant loss in these bone flaps
within their study being 27% in iliac crest, 33% in fibula,
and 100% in radius and that implants placed in composite
fibula and iliac crest flaps performed approximately as well
as in native maxilla within their study’ [31].
Table 3 Implant survival in autogenous bone grafts placed in vascularised and non-vascularised bone grafts
Non-vascularised bone graft Vascularised bone graft
Author Year of
publication
No. of
patients who
had implants
placed into
non-vascularised
autogenous
bone grafts
(and failures)
Overall
patient implant
survival in
non-vascularised
autogenous
bone grafts
No. of implants
placed into
non-vascularised
autogenous
bone grafts
(and failures)
Overall
implant
survival in
non-vascularised
autogenous
bone grafts
No. of
patients who
had implants
placed into
vascularized
autogenous
bone grafts
(and failures)
Overall
patient
implant
survival in
vascularised
autogenous
bone grafts
No. of
implants
placed into
vascularised
autogenous
bone grafts
(and failures)
Overall
implant
survival in
vascularised
autogenous
bone grafts
Studies with an average follow-up of 3 years or greater
Watzinger et al. [29] 1996 Not reported N/A 33 (13) 60.6%* Not reported N/A 19 (1) 94.7%*
Teoh et al. [26] 2005 N/A N/A N/A N/A 22 (2) 90.9%* 71 (3) 95.8%*
Wu et al. [30] 2008 N/A N/A N/A N/A 29 (not reported) N/A 100 (9) 91%
Fenlon et al. [19] 2012 N/A N/A N/A N/A 41 (10) 75.6%* 145 (18) 87.5%*
Ch’ng et al. [20] 2014 N/A N/A N/A N/A 54 (10) 81.5%* 243 (20) 91.8%
Shaw et al. [31] 2005 2 (1) 50%* 8 (2) 75%* 31 (11) 64.5%* 115 (30) 73.9%*
Wang et al. [21] 2015 N/A N/A N/A N/A 19 (0) 100% 51 (0) 100%*
Yerit et al. [16] 2006 Not reported N/A Not reported N/A Not reported N/A Not reported N/A
Linsen et al. [17] 2009 Not reported N/A 79 (8) 89.9%* N/A N/A N/A N/A
Studies with an average follow-up of less than 3 years or no average follow-up reported
Fierz et al. [25] 2013 N/A N/A N/A N/A Not reported N/A Not reported N/A
Barrowman et al. [7] 2011 Not reported N/A 6 (0) 100%* Not reported N/A 32 (5) 84.4%*
Zou et al. [22] 2013 N/A N/A N/A N/A 32 (not reported) N/A 110 (5) 96.4%
Schultes et al. [15] 2002 N/A N/A N/A N/A 38 (2) 94.7%* 96 (2) 97.9%*
Buddula et al. [24] 2010 Not reported N/A Not reported N/A Not reported N/A Not reported N/A
Klein et al. [32] 2009 Not reported N/A 128 (22) 82.8%* N/A N/A N/A N/A
Burgess et al. [27] 2017 N/A N/A N/A N/A 59 (not reported) N/A 199 (11) 93.6%
Chiapasco et al. [18] 2006 N/A N/A N/A N/A 14 (1) 92.9%* 62 (1) 98.3%*
Chiapasco et al. [23] 2008 16 (1) 93.8%* 60 (2) 96.7%* N/A N/A N/A N/A
Chiapasco et al. [33] 2000 10 (1) 90%* 41 (2) 95.1%* 8 (1) 87.5%* 31 (1) 96.8%*
Hessling et al. [28] 2015 Not Reported N/A 62 (4) 93.5%* Not reported N/A 31 (4) 87.1%*
Implant survival in autogenous bone grafts was extracted on a patient and implant level (where applicable) for all 20 studies included within this review that
specifically reported on implant survival in either vascularised or non-vascularised autogenous bone grafts
Those marked with an asterisk have had the survival percentages calculated by the authors due to their being adequate information/data within the studies to
calculate this
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Twelve studies reported on the use of more than one
autogenous bone graft donor site within their study
(Barrowman et al. [7], Schultes et al. [15], Yerit et al. [16],
Fenlon et al. [19], Chiapasco et al. [23], Buddula et al. [24],
Fierz et al. [25], Burgess et al. [27], Hessling et al. [28],
Watzinger et al. [29], Shaw et al. [31] and Chiapasco et al.
[33]); of these, five studies reported on the effect of the
autogenous bone graft donor site on implant survival.
Two studies (Fenlon et al. [19], Burgess et al. [27])
reported no significant effect on implant survival in vary-
ing graft donor sites; however, three studies (Hessling et
al. [28], Shaw et al. [31], Chiapasco et al. [33]) reported
varying implant survival rates within different autogenous
bone grafts but only one study (Hessling et al. [28]) re-
ported that implant loss was significant with this being for
implants placed into fibula bone grafts. Shaw et al,. [31]
reporting that implants placed into ‘vascularized bone
graft were superior to non-vascularized bone. In particu-
lar, those implants in composite radial forearm flaps per-
formed badly. With the proportion of patients with
implant loss in these bone flaps within their study being
27% in iliac crest, 33% in fibula, and 100% in radius and
that implants placed in composite fibula and iliac crest
flaps performed approximately as well as in native maxilla
within their study’ [31].
Radiotherapy and implant survival
Seven studies reported on outcomes related to implant
survival in irradiated autogenous bone grafts (Barrowman
et al. [7], Fenlon et al. [19], Ch’ng et al. [20], Buddula et al.
[24], Fierz et al. [25], Teoh et al. [26], Burgess et al. [27])
(Table 4). One study reported solely on irradiated patients
(Buddula et al. [24]) the other six studies (Barrowman et al.
[7], Fenlon et al. [19], Ch’ng et al. [20], Fierz et al. [25], Teoh
et al. [26], Burgess et al. [27]) reported on both irradiated
and non-irradiated patients. These six studies (Barrowman
et al. [7], Fenlon et al. [19], Ch’ng et al. [20], Fierz et al. [25],
Teoh et al. [26], Burgess et al. [27]) all reported higher
implant failure (at an implant and a patient level (where
applicable)) of implants placed into autogenous bone grafts
in irradiated patients in comparison to those patients who
did not received radiotherapy (Table 4).
All of these studies (Barrowman et al. [7], Fenlon et al.
[19], Ch’ng et al. [20], Fierz et al. [25], Teoh et al. [26],
Burgess et al. [27]) reported on the deleterious effect of
radiotherapy on implant survival in autogenous bone
grafts within their studies and was found to be statistically
significant in two studies (Fenlon et al. [19], Ch’ng et al.
[20]) with Fenlon [19] reporting a close correspondence of
implant survival (in vascularised free composite grafts)
and an absence of radiotherapy using a multiple corres-
pondence analysis and Ch’ng et al. [20] who reported a
statistical significance associated with higher implant
failure in irradiated fibula free flaps in comparison to non-
irradiated fibula free flaps (P = 0.041). However, in two
studies (Teoh et al. [26], Burgess et al. [27]), no statistical
significance was found despite higher implant failure.
Primary and secondary implant placement and implant
survival
Six studies clearly reported the use of both primary and
secondary implant placement within their study (Fenlon
et al. [19], Ch’ng et al. [20], Zou et al. [22], Burgess et al.
[27], Watzinger et al. [29], Wu et al. [30]); however, only
one study (Fenlon et al. [19]) reported on implant survival
in primary and secondary implant placement within
autogenous bone grafts. Felon et al. [19] reported on
implant survival in immediate vs delayed placement of the
implant fixtures into free vascularised grafts and found
that implant survival of immediately placed implants was
significantly worse than that of implants placed after a
delay of 3 months in free vascularized grafts.
Cancer diagnosis and implant survival
With regards to cancer type (malignant vs benign), three
studies (Schultes et al. [15], Watzinger et al. [29], Klein et
al. [32]) reported exclusively on implant survival in patients
with malignant H&N cancers with varying implant survival
rates being reported, whilst one study reported exclusively
on benign H&N cancer patients (Wang et al. [21]) with a
100% implant survival rate being reported (Table 2). Two
studies (Fenlon et al. [19], Burgess et al. [27]) provided
non-descriptive terms (cancer, head and neck neoplasia) for
the type of H&N cancer of the patients within their studies
and therefore differentiation between benign and malignant
disease could not be made. The other 14 studies reported
on both malignant and benign H&N cancers; however, the
implant survival data was not reported or presented in a
way in which comparison of implant survival in patients
with malignant or benign H&N cancers could be made.
Implant survival and Peri-implant soft tissue
Only one study (Linsen et al. [17]) reported on the effect
of the peri-implant soft tissue and implant survival of
implants placed into autogenous bone grafts. Linsen et al.
[17] reported a higher implant failure of implants placed
into bone and soft tissue grafts in comparison to implants
placed into a bone grafts with residual soft tissues. This
difference, however, was not found to be statistically
significant (p = 0.436).
In the other 19 studies, the effect of the peri-implant
soft tissue was not directly reported as being a factor for
implant survival. However, implant success appeared to be
significantly affected by the peri-implant soft tissues (see
the “Implant survival and Implant Success” and “Compli-
cations” sections – for further details).
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Implant survival and implant success
In nine studies (Schultes et al. [15], Fenlon et al. [19], Wang
et al. [21], Zou et al. [22], Chiapasco et al. [18], Chiapasco
et al. [23], Watzinger et al. [29] Wu et al. [30], Chiapasco et
al. [33]), both implant survival and success data was
reported or provided (Table 2). When comparing implant
survival and implant success in eight studies (Schultes et al.
[15], Fenlon et al. [19], Wang et al. [21], Zou et al. [22],
Chiapasco et al. [18], Chiapasco et al. [23], Watzinger et al.
[29], Wu et al. [30], Chiapasco et al. [33]) implant success
was found to be lower than implant survival but in one
study (Chiapasco et al. [33]) implant survival and success
were reported as being the same. The reasons for a lack of
implant success within these eight studies (other than
implant failure/loss) were related to excessive peri-implant
bone loss in five studies (Wang et al. [21], Zou et al. [22],
Chiapasco et al. [18], Chiapasco et al. [23], Wu et al. [30]),
an inability to prosthetically restore the implants in four
studies (Schultes et al. [15], Fenlon et al. [19], Watzinger et
al. [29], Wu et al. [30]) and gingival hyperplasia in one
study (Zou [22]). Six of these studies (Schultes et al. [15],
Wang et al. [21], Zou et al. [22], Chiapasco et al. [18],
Chiapasco et al. [23], Wu et al. [30]) reported some of this
lack of success to the peri-implant soft tissue which was most
frequently the soft tissue component of a combined bone and
soft tissue free flap (most commonly the external skin).
Complications
A variety of implant-based complications were docu-
mented. Complications were often described within the
study rather than being formal assessed, defined or used
as outcome measures. Due to there being a lack of
formal definition and variability in the documentation
within the studies, the data cannot be considered robust
to be collectively appraised but is described for informa-
tion purposes. Common “complications” reported in the
studies include soft tissue overgrowth/hyperplasia of the
peri-implant tissues (Wang et al. [21], Chiapasco et al.
[18], Teoh et al. [26], Wu et al. [30], Shaw et al. [31]),
peri-implantitis and periodontal pocketing (Barrowman
et al. [7], Schultes et al. [15], Linsen et al. [17], Burgess
et al. [27], Hessling et al. [28]), the need for soft tissue
debulking/modification around free flaps (Ch’ng et al.
[20], Shaw et al. [31]) and the need for mucosal/soft
tissue graft around implants to improve the soft tissue
profile (Chiapasco et al. [23], Teoh et al. [26], Chiapasco
et al. [33]). These peri-implant complications were most
commonly seen when the soft tissue profile around the
implant was related to a soft tissue graft and therefore
did not have attached keratinised mucosa which is
needed to provide a soft tissue profile that is conducive
to peri-implant health. Other complications include poor
oral hygiene (Wang et al. [21], Zou [22]), challenging
Table 4 Implant survival in autogenous bone grafts of irradiated & non-irradiated patients
RDX No RDX
Author Year of
publication
No. of
implants
placed into
autogenous
bone grafts
with RDX
(and failures)
Overall
implant
survival
of implants
placed into
autogenous
bone grafts
with RDX
No. of
patients
who had
implants
placed into
autogenous
bone grafts
with RDX
(and failures)
Patient
based
implant
survival
of implant
placed into
autogenous
bone grafts
with RDX
No. of
implants
placed into
autogenous
bone grafts
with no RDX
(and failures)
Overall
implant
survival of
implants
placed into
autogenous
bone grafts
with no RDX
No. of
patients
who had
implants
placed into
autogenous
bone grafts
with no RDX
(and failures)
Patient-based
implant survival
of implant placed
into autogenous
bone grafts with
no RDX
Teoh et al.
[26]
2005 14(2) 85.7%* 4 (1) 75%* 57 (1) 98.2%* 22 (1) 95.4%*
Fenlon
et al. [19]
2012 35 (15) 57.1%* 12 (8) 33.3%* 110 (3) 97.3%* 29 (2) 93.1%*
Ch’ng et al.
[20]
2014 66 (11) 83.3%* Not reported N/A 177 (9) 94.9%* Not reported N/A
Fierz et al.
[25]
2013 20 (6) 70.0%* Not reported N/A 26 (2) 92.3%* Not reported N/A
Barrowman
et al. [7]
2011 15 (5) 66.7%* Not reported N/A 23 (0) 100%* Not reported N/A
Buddula
et al. [24]
2010 59 (8) 83.3% Not reported N/A N/A N/A N/A N/A
Burgess
et al. [27]
2017 45* (7) 84.4%* Not reported N/A 154 (4) 97.4%* Not reported N/A
Implant survival in autogenous bone grafts of irradiated and non-irradiated patients was extracted on an implant and patient level (where applicable) for seven
studies that reported on implant survival of implants placed in autogenous bone grafts
Those marked with an asterisk have had the survival percentages calculated by the authors due to their being adequate information/data within the studies to
calculate this
Abbreviations: RDX radiotherapy
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prosthodontic rehabilitation/inability to tolerate the
prosthesis provided (Barrowman et al. [7], Zou et al.
[22], Fierz et al. [25]), poor implant position (Schultes et
al. [15], Fenlon et al. [19], Watzinger et al. [29], Wu et al.
[30]) and osteoradionecrosis (Ch’ng et al. [20]) (Table 2).
Discussion
Summary of evidence
Dental implants are now perceived to be a vital part of the
clinician’s armamentarium in the provision of oral and
dental rehabilitation for patients with acquired deformity
following management of their H&N cancer, and there-
fore, this systematic review is relevant to clinicians and
stakeholders involved in the treatment and management
of H&N cancer patients specifically with those involved in
placing or utilising dental implants to assist in the dental/
oral rehabilitation of H&N cancer patients.
The main findings from this systematic review did
however identify, with the exception of a small number of
studies, implant survival (at an implant level) in autogen-
ous bone grafts was clinically promising (> 85%); however,
this appears to be lower than implants placed into the
native bone in H&N cancer patients. Weak evidence was
identified which suggests that radiotherapy is a prognostic
factor affecting implant survival in this patient cohort;
however, this has also been reported as having a detrimen-
tal effect on implant survival in the native bone within the
literature [34]. The type of autogenous bone graft donor
site and implant survival was also reviewed within the
included studies that compared varying autogenous bone
graft donor sites and implant survival. There is some weak
evidence from these studies to suggest that implants
placed into vascularised bone grafts appear to have a
higher survival rate in comparison to non-vascularised
bone grafts within this review. This evidence however is
unreliable, due to the clear lack of studies reporting on
implant survival in non-vascularised bone grafts and thus
the subsequent number of implants and patients included
within this review. Implant survival did not appear to be
affected by the type of H&N cancer type (malignant vs.
benign); however, no studies within this review directly
compared or enabled the authors of this manuscript to
compare studies, and accordingly, no true conclusion can
be made on this.
The implant placement protocol with regard to primary
(immediate) or secondary (delayed) implant placement
was also reviewed, and there is limited evidence from
Fenlon et al. that implant failure is significantly worse in
immediately placed implants in comparison with a delayed
approach in free vascularized grafts.
Implant success was shown to be lower than implant
survival and was related to peri-implant bone loss, peri-
implant hyperplasia and an inability to prosthetically
restore the implants. This was most commonly related to
combined bone and soft tissue grafts, specifically the soft
tissue component. This soft tissue component provides a
suboptimal soft tissue profile which could contribute to
implant failure (as a result of peri-implantitis); however,
well-designed long-term studies are needed to fully com-
prehend the effect on implant survival.
Implant complications were also noted specific to
autogenous bone grafts related to peri-implant soft
tissue overgrowth/hyperplasia and the possible need for
soft tissue debulking/modification and mucosal/soft
tissue graft around implants, which occurred commonly
in combined bone and soft tissue grafts. These finding,
however, are limited to low-level evidence in the form of
a small number of retrospective observational studies.
Limitations
This systematic review has identified that the quality of
evidence to inform clinical decision making regarding
the use of implants in transported bone in this patient
group is currently deficient. All studies included in the
review were retrospective observational studies and in
general reported on low patient and implant number
and found to be at moderate to serious risk of bias.
A lack of consistency in definitions of the primary
(implant related) outcome measures was observed. The
outcome measures used in the studies varied and implant
survival/success was not necessarily the primary outcome
measure. Only 14 of the 20 studies reported the primary
outcome measure to be implant survival/success whilst the
remainder reported free flap survival, graft success and
bone resorption of bone grafts as the primary outcome.
A clear deficiency of many of the studies was the im-
precise and inconsistent definitions of implant survival
or implant success, as detailed in Table 1. In addition, in
a number of studies, the terminology ‘implant success’
and ‘implant survival’ were used interchangeably within
the narrative making comparison of the studies challen-
ging and rendering statistical analysis of the survival data
inappropriate.
The reporting of implant survival data varied between
studies and was presented in a variety of ways which in-
cluded cumulative survival and implant survival incidence.
In some cases, no attempt to estimate survival was made
but adequate data was documented to enable its calcula-
tion (Table 2). Best practice would be the reporting of
cumulative survival to give context to survival (time) and
account for patient drop-out which may be high in this
particular patient group. Due to the variability in the
methods of data reporting and their comprehensiveness,
there was insufficient confidence in extracted data to
report statistical findings. Notably, as all studies presented
different deficiencies in data reporting or study definitions,
there was no clear way to further exclude studies using
these criteria.
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As such, there is a clear need for a consensus on what
minimum data set is required for published articles report-
ing on implant survival in this patient cohort to allow fur-
ther investigation via systematic reviews (e.g., effect of
benign vs malignant H&N cancer and implant survival).
The inclusion and exclusion criteria were highly variable,
and in some studies, the criteria were such that there was
a pre-disposition to selection bias and reporting higher
implant survival rates. Patient follow-up was variable and
also variably reported but in general was insufficient.
Where possible, follow-up of at least 5 years is required to
begin to evaluate the outcome of dental implant treat-
ment. Unfortunately, information on long-term dental
survival in this cohort is still scarce and the results of the
present review should not be extrapolated beyond early
implant survival.
Conclusion
Within the limitations of the current review, it can be
concluded that implant survival in autogenous bone
grafts in H&N oncology patients appears to be promis-
ing with implant survival being reported at over 80% in
16 of the 20 studies included with 11 of these reporting
implant survival of over 90% in follow-up ranging from
3 months [28] to 15 years [5]. However, there is a lack
of good quality evidence in the way of prospective stud-
ies and randomised control trials. A lack of long-term
survival studies with sufficient implant and patient
numbers was identified, and therefore, the results of
the present review should not be extrapolated to longer
follow-up times. Prognostic factors affecting implant
survival in autogenous bone grafts were also reviewed
with higher implant failure in autogenous bone grafts
being reported in implants placed into irradiated au-
togenous bone grafts. Weak evidence suggesting
implant failure was higher in non-vascularised in com-
parison with vascularised autogenous bone grafts and
that implant failure was greater in primary placed im-
plants in vascularised bone grafts in this cohort was
identified. Implant success was lower than implant sur-
vival and was most commonly related to peri-implant
disease and an inability to prosthetically to restore the
implant. This was predominantly related to unfavour-
able peri-implant soft tissue which is frequently found
around implants placed into combined bone and soft
tissue flaps.
In order to understand the use of implants in autogen-
ous bone grafts in H&N oncology patients larger, well-
designed prospective studies are required. There needs
to be clear set definitions of implant survival and success
and appropriate presentation and statistical analysis of
the data so that studies can be brought together to
enable meta-analysis.
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